GAO publishes report on status of HRSA recommendations
In its 2011 report, the Government Accountability Office (GAO) found that the Health Resources and Services Administration’s (HRSA) oversight of the 340B Drug Pricing Program was insufficient to deliver an equitable guarantee that program participants were in compliance with program requirements. Read More »